Indole derivatives
    3.
    发明授权
    Indole derivatives 失效
    吲哚衍生物

    公开(公告)号:US07291644B2

    公开(公告)日:2007-11-06

    申请号:US11412879

    申请日:2006-04-28

    摘要: Compounds represented by formula (I) wherein all symbols represent the same meanings as described in specification and salts thereof. Since the compound represented by the formula (I) binds and antagonizes to DP receptor, it is useful for the prevention or treatment against the disease such as allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease, and ulcerative colitis.

    摘要翻译: 由式(I)表示的化合物,其中所有符号表示与说明书及其盐中所述相同的含义。 由于式(I)表示的化合物与DP受体结合并拮抗,因此可用于预防或治疗诸如过敏性疾病,伴有瘙痒的疾病,由瘙痒引起的行为引起的继发性疾病,炎症,慢性 阻塞性肺病,局部缺血再灌注障碍,类风湿关节炎并发的胸膜炎,脑血管疾病和溃疡性结肠炎。

    Indole derivatives, process for preparation of the same and use thereof
    8.
    发明授权
    Indole derivatives, process for preparation of the same and use thereof 失效
    吲哚衍生物,其制备方法及其用途

    公开(公告)号:US06743793B2

    公开(公告)日:2004-06-01

    申请号:US10220806

    申请日:2002-12-13

    IPC分类号: C07D20900

    摘要: Indole derivatives represented by formula (I): (wherein all symbols are described in the description), a process for the preparation of the same and a DP receptor antagonist comprising it as an active ingredient. Since the compounds of formula (I) binds to and are antagonistic to a DP receptor, they are useful in for the prevention and/or treatment of diseases, for example, allergic diseases (allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, etc., systemic mastocytosis; disorders due to systemic mastocyte activation, anaphylactic shock, bronchoconstriction, urticaria, eczema, etc.), diseases accompanied with itching (atopic dermatitis, urticaria, etc.), secondary diseases caused by behaviors (scratching behaviors, beating, etc.) (cataract, retinal detachment, inflammation, infection, sleep disorder, etc.), inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, cerebrovascular disorder, pleuritis complicated by rheumatoid arthritis, ulcerative colitis, and the like.

    摘要翻译: 由式(I)表示的吲哚衍生物:(其中所有符号在描述中描述),其制备方法和包含其作为活性成分的DP受体拮抗剂。 由于式(I)化合物与DP受体结合并拮抗DP受体,它们可用于预防和/或治疗疾病,例如过敏性疾病(过敏性鼻炎,过敏性结膜炎,特应性皮炎,支气管哮喘, 食物过敏等,系统性肥大细胞增多症;由于系统性肥大细胞活化引起的疾病,过敏性休克,支气管收缩,荨麻疹,湿疹等),伴有瘙痒的疾病(特应性皮炎,荨麻疹等),行为引起的继发性疾病 行为,殴打等)(白内障,视网膜脱离,炎症,感染,睡眠障碍等),炎症,慢性阻塞性肺病,缺血再灌注障碍,脑血管障碍,类风湿性关节炎并发溃疡性结肠炎等的胸膜炎 。

    Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient
    9.
    发明授权
    Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient 有权
    羧酸化合物和包含该化合物作为活性成分的药剂

    公开(公告)号:US07351705B2

    公开(公告)日:2008-04-01

    申请号:US10507885

    申请日:2003-03-06

    摘要: A carboxylic acid compound represented by formula (I): (meanings of the symbols in the formula are as mentioned in the specification) and a pharmaceutical agent comprising the compound. Since the compound represented by formula (I) binds to a DP receptor and shows antagonistic activity for the DP receptor, it is useful for prevention and/or treatment of diseases such as allergic disease (such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, urticaria, eczema, diseases accompanied by itch (such as atopic dermatitis and urticaria), diseases (such as cataract, retinal detachment, inflammation, infection and sleeping disorders) which is generated secondarily as a result of behavior accompanied by itch (such as scratching and beating), inflammation, chronic obstructive pulmonary diseases, ischemic reperfusion injury, cerebrovascular accident, chronic rheumatoid arthritis, pleurisy, ulcerative colitis and the like.

    摘要翻译: 由式(I)表示的羧酸化合物:(式中符号的含义如说明书中所述)和包含该化合物的药剂。 由于式(I)表示的化合物与DP受体结合,对DP受体具有拮抗作用,因此可用于预防和/或治疗过敏性疾病(如过敏性鼻炎,过敏性结膜炎,特应性皮炎, 支气管哮喘和食物过敏),系统性肥大细胞增多症,伴有系统性肥大细胞活化的疾病,过敏性休克,支气管收缩,荨麻疹,湿疹,伴有瘙痒的疾病(如特应性皮炎和荨麻疹),疾病(如白内障,视网膜脱离,炎症 ,感染和睡眠障碍),其由伴随瘙痒的行为(例如搔抓和殴打),炎症,慢性阻塞性肺疾病,缺血再灌注损伤,脑血管意外,慢性类风湿性关节炎,胸膜炎,溃疡性结肠炎和 喜欢。

    Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
    10.
    发明申请
    Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient 有权
    羧酸化合物和含有与活性成分相同的药物组合物

    公开(公告)号:US20070004716A1

    公开(公告)日:2007-01-04

    申请号:US10572578

    申请日:2004-09-16

    IPC分类号: A61K31/538 C07D265/36

    摘要: A compound represented by formula (I) wherein the symbols in the formula are the same meanings as those in specification, salts thereof, solvates thereof, or prodrugs thereof binds to DP receptor and shows antagonistic activity for DP receptor. Thus, it is useful for prevention and/or treatment of diseases such as allergic disease (e.g., allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, urticaria, eczema, diseases accompanied by itch (e.g., atopic dermatitis and urticaria), diseases (e.g., cataract, retinal detachment, inflammation, infection and sleeping disorders) which is generated secondarily as a result of behavior accompanied by itch (e.g., scratching and beating), inflammation, chronic obstructive pulmonary diseases, ischemic reperfusion injury, cerebrovascular accident, chronic rheumatoid arthritis, pleurisy, ulcerative colitis, etc. Since it specifically binds to DP receptor and binds weakly to other prostaglandins receptors, they can be pharmaceuticals having little side effect.

    摘要翻译: 由式(I)表示的化合物,其中式中的符号与说明书中的符号相同,其盐,溶剂合物或其前药与DP受体结合并显示DP受体的拮抗活性。 因此,它可用于预防和/或治疗过敏性疾病(例如过敏性鼻炎,过敏性结膜炎,特应性皮炎,支气管哮喘和食物过敏),系统性肥大细胞增多症,伴有全身性肥大细胞活化的病症,过敏性休克, 支气管收缩,荨麻疹,湿疹,伴有瘙痒的疾病(例如特应性皮炎和荨麻疹),伴随瘙痒的行为的结果产生的疾病(例如白内障,视网膜脱离,炎症,感染和睡眠障碍)(例如, 搔抓和殴打),炎症,慢性阻塞性肺疾病,缺血再灌注损伤,脑血管意外,慢性类风湿关节炎,胸膜炎,溃疡性结肠炎等。由于其特异性结合DP受体并且弱结合到其他前列腺素受体,它们可以是具有 小副作用。